869199-62-2 Usage
Uses
Used in Medicinal Chemistry Research:
N-(6-amino-7-methoxy-quinazolin-4-yl)-N-(3-chloro-4-fluoro-phenyl)-acetamide is used as a research compound for the development of potential pharmaceutical agents. Its unique structure and functional groups make it a promising candidate for the discovery of new drugs with potential therapeutic applications.
Used in Drug Development:
In the pharmaceutical industry, N-(6-amino-7-methoxy-quinazolin-4-yl)-N-(3-chloro-4-fluoro-phenyl)-acetamide is used as a starting material or intermediate in the synthesis of new drug molecules. Its chemical properties and structural features can be exploited to design and optimize compounds with desired biological activities and pharmacological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 869199-62-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,1,9 and 9 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 869199-62:
(8*8)+(7*6)+(6*9)+(5*1)+(4*9)+(3*9)+(2*6)+(1*2)=242
242 % 10 = 2
So 869199-62-2 is a valid CAS Registry Number.
869199-62-2Relevant academic research and scientific papers
4-Phenylamino-quinazolin-6-yl-amides
-
Page/Page column 18-20, (2010/02/14)
This invention provides quinazoline compounds of the formula: wherein: R1 is halo; R2 is H or halo; R3 is a) C1-C3 alkyl, optionally substituted by halo; or b) —(CH2)n-morpholino, —(CH2)n-piperidine, —(CH2)n-piperazine, —(CH2)n—-piperazine-N(C1-C3 alkyl), —(CH2)n-pyrrolidine, or —(CH2)n-imidazole; n is 1 to 4; R4 is —(CH2)m-Het; Het is morpholine, piperidine, piperazine, piperazine-N(C1-C3 alkyl), imidazole, pyrrolidine, azepane, 3,4-dihydro-2H-pyridine, or 3,6-dihydro-2H-pyridine, each optionally substituted by alkyl, halo, OH, NH2, NH(C1-C3 alkyl) or N (C1-C3 alkyl)2; m is 1-3; and X is O, S or NH; or a pharmaceutically acceptable salt thereof, as well as processes and intermediate compounds for making them, useful pharmaceutical compositions and methods of using the compounds in the treatment of proliferative diseases.
